Adjuvant Folfox4+/- Cetuximab In Kras Wild-Type Patients With Resected Stage Iii Colon Cancer Results From The Petacc8 Intergroup Trial
AuthID
P-002-96W
P-002-96W
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service